FDAClass II · Drug · Recalled July 1, 2026

Lacosamide Tablets recall — Annora Pharma Private Limited

Hazard: Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID: D-0626-2026
Brand: Annora Pharma Private
Classification: Class II
Units affected: 31,392 60-count bottles
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Description

Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.

Affected products

Lacosamide Tablets

Companies & origin

Recalling firm location: Hyderabad, N/A, India
Firm address: Sy. No.261, Plot No. 13 And 14, Annaram Village, Gummadidal Mandal, Jinnaram Mandal, Sangareddy District, Medak, N/A

Identifying details (verbatim from the notice)

Product codes / lots: Lot: A253999, A254000, Expires: 09/30/2027.
Distribution: Nationwide in the USA
Firm notified the public via: E-Mail
FDA event ID: 99200
Recall initiated: June 4, 2026
FDA classified: June 25, 2026
FDA report date: July 1, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 12:00 AM UTC.

Report a data error on this page